Nipp Ryan D, Sonet Ellen Miller, Guy Gery P
From the Department of Medicine, Division of Hematology and Oncology, Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, MA; CancerCare, New York, NY; Divisions of Unintentional Injury Prevention and Cancer Prevention and Control, Centers for Disease Control and Prevention, Atlanta, GA.
Am Soc Clin Oncol Educ Book. 2018 May 23;38:524-531. doi: 10.1200/EDBK_201051.
In recent years, high health care costs and the financial burden of cancer care have received increased attention. In response to the financial burden of cancer care, patients may jeopardize their health outcomes by not properly adhering to prescribed therapies or even forgoing and delaying care in an effort to defray costs. In addition, the financial burden experienced by patients with cancer may negatively impact clinical outcomes, such as quality of life, physical and psychological symptoms, and potentially, even survival. Notably, in the current era of targeted treatment and immunotherapies for patients with cancer, the rising costs of cancer continue to remain at the forefront of patient concerns. Therefore, a critical need exists to determine how best to assist patients with the cost burden of cancer diagnosis and treatment.
近年来，高昂的医疗保健成本以及癌症治疗的经济负担受到了越来越多的关注。为应对癌症治疗的经济负担，患者可能会因未正确坚持规定的治疗方法，甚至为了支付费用而放弃或推迟治疗，从而危及他们的健康状况。此外，癌症患者所承受的经济负担可能会对临床结果产生负面影响，如生活质量、身体和心理症状，甚至可能影响生存。值得注意的是，在当前针对癌症患者的靶向治疗和免疫疗法时代，癌症治疗费用的不断上涨仍然是患者关注的首要问题。因此，迫切需要确定如何最好地帮助患者应对癌症诊断和治疗的费用负担。
Zotero 插件